Beijing Minhai Biotechnology Co., Ltd is a leading supplier to the pharmaceutical industry, specialising in biopharmaceuticals with a strong focus on vaccine development and manufacturing. The company offers a wide range of vaccines including the 13-valent pneumococcal conjugate vaccine, the 23-valent pneumococcal polysaccharide conjugate vaccine, the hepatitis B vaccine, varicella vaccine, rabies vaccine, DTaP-Hib, Hib, DTaP, pentavalent vaccine, IPV vaccine, TT vaccine, MMR vaccine, and the 4-valent influenza vaccine.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Vaccine development and manufacturing
– Quality control and assurance
– Regulatory affairs consulting
– Research and development support

Beijing Minhai Biotechnology Co., Ltd is committed to supporting the pharmaceutical industry with innovative biopharmaceutical solutions. For more information, please visit biominhai.com.